Novel 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives displaying combined norepinephrine reuptake inhibition and 5-HT2A/2C receptor antagonism.

J. Bartolome,A. Alcudia,J. Andrés,J. Cid,M. García,A. Megens,M. Toledo,A. Trabanco
DOI: https://doi.org/10.1016/J.BMCL.2005.03.076
IF: 2.94
2005-06-02
Bioorganic & Medicinal Chemistry Letters
Abstract:
What problem does this paper attempt to address?